InsiderClue
Insiders · Profile

Malley Thomas

Director at Kiniksa Pharmaceuticals International · Director at Kura Oncology · Director at BeOne Medicines · and 2 more. Filing since 7 Jun 2012. CIK 0001403322

KNSA Kiniksa Pharmaceuticals International, plc Director · 3 trades KURA Kura Oncology, Inc. Director · 2 trades ONC BeOne Medicines Ltd. Director · 1 trade TPST Tempest Therapeutics, Inc. Director · 3 trades PBYI PUMA BIOTECHNOLOGY, INC. Director · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
KNSA Kiniksa Pharmaceuticals International, plc
14 Aug 2025
Director
Sold at will
78,233
$2.59M
86.2%
KNSA Kiniksa Pharmaceuticals International, plc
13 Aug 2025
Director
Sold at will
50,129
$1.67M
80.0%
KNSA Kiniksa Pharmaceuticals International, plc
12 Aug 2025
Director
Sold at will
49,407
$1.60M
79.7%
KURA Kura Oncology, Inc.
16 Jun 2023
Director
Bought
50,000
$575.00K
55.8%
ONC BeOne Medicines Ltd.
23 Nov 2016
Director
Bought
30,000
$960.00K
opened
KURA Kura Oncology, Inc.
10 Nov 2015
Director
Bought
50,000
$400.00K
126%
TPST Tempest Therapeutics, Inc.
8 Apr 2015
Director
Bought
5,000
$142.50K
4.3%
TPST Tempest Therapeutics, Inc.
13 Jan 2015
Director
Bought
35,000
$1.75M
42.8%
TPST Tempest Therapeutics, Inc.
18 Mar 2013
Director
Bought
50,000
$450.00K
157%
PBYI PUMA BIOTECHNOLOGY, INC.
24 Oct 2012
Director
Bought
10,000
$160.00K
6.8%
PBYI PUMA BIOTECHNOLOGY, INC.
11 Jun 2012
Director
Bought
10,032
$125.40K
7.3%
PBYI PUMA BIOTECHNOLOGY, INC.
8 Jun 2012
Director
Bought
8,168
$102.10K
6.4%
PBYI PUMA BIOTECHNOLOGY, INC.
7 Jun 2012
Director
Bought
1,800
$22.50K
1.4%
13 decisions on file.